Amplia Therapeutics Limited

IRM Services
Ticker Code
ATX
Market Cap ($m)
12
Market Cap As At
11/10/2018
GICS Industry Group
Pharmaceuticals, Biotechnology & Life Sciences
Company Description
Amplia Therapeutics Limited is an Australian pharmaceutical company advancing a pipeline of Focal Adhesion Kinase (FAK) inhibitors for cancer and fibrosis. FAK is an increasingly important target in the field of cancer immunology and Amplia has a particular development focus in pancreatic and ovarian cancer. FAK also plays a significant role in a number of chronic diseases, such as idiopathic pulmonary fibrosis (IPF).
alt